Tudor Investment Corp’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-48,169	Closed	-$169K	–	3253
2024 Q3	$169K	Buy	48,169 +2,879	+6%	+$11.2K	﹤0.01%	2561
2024 Q2	$149K	Sell	45,290 -2,792	-6%	-$12.2K	﹤0.01%	2183
2024 Q1	$353K	Buy	+48,082	New	+$298K	﹤0.01%	1795
2023 Q4	–	Sell	-50,187	Closed	-$106K	–	2575
2023 Q3	$106K	Sell	50,187 -4,424	-8%	-$14.7K	﹤0.01%	2146
2023 Q2	$260K	Buy	54,611 +2,177	+4%	+$12K	﹤0.01%	2079
2023 Q1	$299K	Sell	52,434 -350	-0.7%	-$2.11K	0.01%	1935
2022 Q4	$533K	Buy	52,784 +5,785	+12%	+$109K	0.01%	1540
2022 Q3	$1.05M	Buy	46,999 +10,284	+28%	+$297K	0.03%	877
2022 Q2	$910K	Buy	36,715 +21,601	+143%	+$596K	0.03%	946
2022 Q1	$586K	Sell	15,114 -18,401	-55%	-$713K	0.02%	1181
2021 Q4	$1.96M	Buy	+33,515	New	+$1.9M	0.04%	637
2021 Q2	–	Sell	-3,560	Closed	-$294K	–	1697
2021 Q1	$294K	Buy	+3,560	New	+$341K	0.01%	1315
2020 Q4	–	Sell	-42,035	Closed	-$1.68M	–	1412
2020 Q3	$1.68M	Buy	42,035 +4,325	+11%	+$151K	0.07%	363
2020 Q2	$1.29M	Buy	+37,710	New	+$1.12M	0.07%	396
2019 Q4	–	Sell	-46,484	Closed	-$722K	–	1214
2019 Q3	$722K	Buy	+46,484	New	+$891K	0.03%	599

Other funds holding FATE